Phyton Biotech, LLC / NIcht bearbeiten, doppelt Our company owns and operates the world's largest cGMP plant cell culture facility with bioreactors specifically designed to meet the need of plant cells in culture as well as preformulation and quality control. The total production capacity of the taxanes train runs up to 880.000 Litres/year. A second fermenter line (Biosafety Level 1) with fermenters up to 7.500 L has been set up most recently in a physically separated area of the plant. Certain downstream equipment for separation, filtration and purification has been installed in parallel. This set up addresses the need for the production of recombinant proteins. Our team is dedicated to demanding, sophisticated large scale fermentation and pharmaceutical production. It offers many years of Manufacturing, Quality Management and Quality Control experience and has been expanded significantly to cover the needs of our extended business. In 2009 we acquired Natural Pharmaceuticals, Inc. (NPI) and offer full downstream production of paclitaxel and docetaxel Active Pharmaceutical Ingredients (API).